Simplex Trading’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Simplex Trading’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-38	Closed	-$1K	–	11395
2022 Q1	$1K	Sell	38 -75	-66%	-$2.79K	﹤0.01%	10186
2021 Q4	$5K	Buy	+113	New	+$6.77K	﹤0.01%	9595

Other funds holding ASLN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Simplex Trading's ASLN Position: Q3 2024 in Review

Simplex Trading sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 220 shares — an estimated $412 sold.

Simplex Trading first reported a position in ASLN in Q2 2022 and held it in 8 quarters. The position peaked at $8K in Q2 2023. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

Simplex Trading reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
Simplex Trading sold 220 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $412.
Simplex Trading first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q2 2022 and held it in 8 quarters.
Simplex Trading's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $8K in Q2 2023.
1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.